Ki-67 assessment is a key step in the diagnosis of neuroendocrine neoplasms (NENs) from
all anatomic locations. Several challenges exist related to quantifying the Ki-67 proliferation …

Simple Summary Cellular proliferation is a central determinant of breast cancer recurrence
risk and response to chemotherapy. The discovery of the Ki-67 antibody by Dr. Johannes …

Background Artificial intelligence (AI) is rapidly fuelling a fundamental transformation in the
practice of pathology. However, clinical integration remains challenging, with no AI …

This is a review on the use of artificial intelligence for digital breast pathology. A systematic
search on PubMed was conducted, identifying 17,324 research papers related to breast …

Background The molecular biomarkers of breast ductal carcinoma in situ (DCIS) have
important guiding significance for individualized precision treatment. This study was …

Background Precision oncology relies on molecular diagnostics, and the value-proposition
of modern healthcare networks promises a higher standard of care across partner sites. We …

Introduction: Breast cancer is the most common cancer in women; its early detection plays a
crucial role in improving patient outcomes. Ki-67 is a biomarker commonly used for …

Aims The nuclear proliferation biomarker Ki67 plays potential prognostic and predictive
roles in breast cancer treatment. However, the lack of interpathologist consistency in Ki67 …

Simple Summary Lung neuroendocrine neoplasms (lung NENs) are categorised by
morphology, defining a classification sometimes unable to reflect ultimate clinical outcome …

Objective: To validate the concordance of automated detection of Ki67 in digital images of
breast cancer with the manual eyeball/hotspot method. Study Design: Descriptive study …